Yes, I do think the act is, generally speaking, well written. It covers a lot of transactions, a lot of foreign investment acquisitions—virtually all. Where I think there is a potential gap is in some of the areas that Mr. Balsillie has been talking about, which is with respect to technology transfers.
For example, if you acquire a company with sensitive IP, that is subject to review. If that company enters into an agreement with a foreign entity to transfer that IP to the foreign entity, that's not subject to review. The effect is the same—the foreign buyer, the foreign entity, has control of the IP or has access to the IP—but one type of commercial arrangement is subject to review and scrutiny, and the other type of commercial transaction, commercial arrangement, is not subject to review and scrutiny.
I think it would be prudent to look at the legislation to see whether or not there are gaps that can be filled, like the one that I just gave by way of example.